Abstract
Introduction
Papillary thyroid cancer (PTC) will manifest regional cervical lymphatic metastases in as many as 25 to 80% of cases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Th e management of these metastases in PTC remains controversial. Multiple authors advocate an elective nodal dissection of the central neck compartment (level VI) at the time of thyroidectomy because of the high incidence of occult metastases, the possibility of more accurate pathologic tumor staging, and the increased risk to the recurrent laryngeal nerves and parathyroid glands if delayed central compartment dissection is performed. [7] [8] [9] [10] [11] [12] [13] Th e best management approach for lateral cervical metastases in PTC remains unclear. While it is recognized that PTC has a high incidence of occult disease, the majority of patients will never manifest lateral cervical nodal involvement. Figure 1 shows the levels of lymph nodes in the neck region. In patients who present with clinically involved lateral cervical lymph nodes (levels II to V), most authors recommend a neck dissection (ND). 1, 3, 5, 8, 11, 13 Th e type of ND performed can range from a super-selective ND (i.e., excision of a single nodal echelon) to a complete, comprehensive ND (levels II to V). 14, 15 Kupferman et al recently reported a clinical series that demonstrated metastatic involvement in level III nodes (57%), as well as involvement of levels II, IV, and V in 21 to 52% of specimens.
11 Th e authors recommended a comprehensive ND (levels II to V) given the high incidence of multilevel nodal metastases. Th is study made no distinction regarding levels II-B (submuscular recess) and level V-A in terms of metastatic lymph node distribution.
Recent reports of patients with squamous cell carcinoma of the larynx would suggest that certain lymph node levels (especially level II-B) may not require dissection, thus shortening operative time and minimizing potential morbidity to the spinal accessory nerve. 16 Several authors patients who underwent primary ND at the time of total thyroidectomy and (2) patients who had undergone a previous thyroidectomy and presented with delayed cervical metastases. Th e diagnosis of regional cervical metastases was based on clinical examination (palpable cervical lymphadenopathy) and a variety of imaging studies, including ultrasound, whole-body I-131 scanning, computed tomography, and magnetic resonance imaging (MRI). Radiographically suspicious lymph nodes then underwent FNA biopsy. Lymph node levels were defi ned according to the anatomic boundaries described in a recent update on classifi cation of ND surgery. 15 Th e majority of patients underwent a selective ND (levels II to V) with preservation of the sternocleidomastoid muscle, internal jugular vein, and spinal accessory nerve as dictated by operative fi ndings. Level I lymph nodes were removed in selected cases in which preoperative imaging or operative fi ndings indicated extension into level I nodes or structures. Th e specimens were oriented on the operative fi eld by the senior surgeon and cut into individual specimens including levels II-A, II-B, III, IV, V-A, V-B, and level I (if removed).
All NDs were evaluated according to a protocol that has been previously described. Briefl y, lymph nodes were meticulously removed from the specimen and measured in 3 dimensions. Either representative sections or the entire specimen was submitted for processing and preparation of histologic sections. One hematoxylin-eosin-stained glass slide was evaluated for each tissue block submitted. Additional levels were prepared as necessary. Th e total number of lymph nodes identifi ed and the number and size of lymph nodes containing metastatic tumor were reported by anatomic level. Routine thyroglobulin staining was not performed.
Results
Th irty-two patients (13 men and 19 women; mean age 45 years [range: 19 to 72 years]) met the criteria as described above for entrance into this study. Eighteen patients underwent a total thyroidectomy with primary ND, and 14 had undergone previous thyroidectomy with delayed cervical metastasis at an average of 29 months post-thyroidectomy. Of the 18 patients who underwent primary ND, 7 underwent bilateral procedures, for a total of 39 NDs. All patients underwent NDs from levels II through V, and 6 of the 39 specimens included level I nodes. Th e fi nal analysis of the 32 patients revealed 22 (69%) patients with a pathologic diagnosis of PTC, 4 (13%), with tall cell variants of PTC, and 6 (19%) with also have noted that the ability to eliminate the dissection of the upper jugular lymph nodes (levels II-B and V-A) may shorten operative time and minimize potential morbidity to the spinal accessory nerve. 8, 9, 16 Th e purpose of this project was to assess the pattern of cervical lymph node metastases in PTC with an emphasis on lymph node distribution in the upper neck region (levels II-B and V-A). In particular, can the surgeon avoid dissection of levels II-B and V-A to avoid dissection of the spinal accessory nerve, yet still provide an oncologically sound clearance of occult cervical metastatic disease?
Patients and methods
Th is project consisted of a retrospective study designed to analyze lymph node distribution in patients diagnosed with PTC who underwent a ND from 2000 to 2007 under the supervision of one surgeon (F.R.M.). Patients were eligible for study analysis if they had a diagnosis of PTC (including the follicular variant) pathologically confi rmed either by fi ne-needle aspiration (FNA) biopsy or previous thyroidectomy, and if they required a ND as part of the treatment plan. Patients with follicular or medullary thyroid cancer were not included in the analysis.
Th e study population consisted of two groups: (1) follicular variants of PTC. An average of 43 lymph nodes was obtained for each ND specimen. Th e incidence of positive nodes for levels II through V are as follows: level IIA 49% (19/39); level IIB 62% (24/39); level III 72% (28/39); level IV 67% (26/39); level V-A 8% (3/39); level V-B 31% (12/39). In 3 of the 6 patients (50%) that underwent a level I lymph node dissection, the specimen contained metastatic disease. All patients who underwent primary ND and 13 of the 14 patients who underwent secondary ND had positive lymph nodes in at least one level. Overall, 72% (28/39) of all specimens contained metastatic disease in multiple lymph node levels.
Discussion
Th e defi nitive management of cervical metastases in PTC remains controversial. Historic data would suggest that clinically palpable or radiographically positive lymph nodes can be detected in as many as 20 to 40% of patients with PTC while as many as 80 to 90% of this same patient population may have occult nodal metastases. 3, 5, 8, 11 In patients with no clinical/radiographic evidence of regional lymph node involvement, several authors have recommended elective central lymph node compartment dissection (level VI). Th e elective removal of the central lymph node compartment (fi rst nodal echelon) is advocated based on the argument that it will remove any occult disease, provide defi nitive pathologic staging, lower the need for central neck revision surgery and, theoretically, improve locoregional control and long-term disease-free survival. 7, 8, 12, 13 Occult metastatic disease in the lateral neck is common, but most authors agree that there is little role for elective lateral ND in the management of PTC. 5, 6, 8, 11 In patients who present with clinically or radiographically confi rmed metastatic PTC in the lateral cervical compartment, the surgeon must decide on the appropriate lymph node levels to remove. Kupferman et al demonstrated a high incidence of metastatic disease in levels II and III (52 and 57%, respectively) and multilevel lymph node metastases in 68% of the patients. 11 Given these fi ndings, the authors recommended a comprehensive ND of levels II to V for complete clearance of lateral cervical metastases. No breakdown of lymph node distribution to level II-A/II-B or V-A/V-B was provided.
Recent publications regarding patients with head and neck squamous cell carcinoma have shown a very low incidence of lymph node metastases to level II-B (submuscular recess). 16, 17 Silverman et al reported an incidence of metastases to level II-B of 1.6% in clinically node-negative necks and 11.1% in clinically nodepositive necks, with an overall incidence of 4.4%. 16 Th e primary tumor sites included the oral cavity, oropharynx, hypopharynx, and larynx. 16 Dissection and removal of the level II-B lymph nodes requires an extensive dissection and mobilization of the proximal portion of the spinal accessory nerve (SAN). Traction injury and disruption of the blood supply to the SAN can result in signifi cant postoperative shoulder dysfunction and pain. 16, 17 We are not aware of any studies that have looked at the lymph node distribution in levels II-B and V-A in patients with well-diff erentiated thyroid cancer (WDTC). Th e obvious benefi t of not having to dissect these levels is a quicker and simpler operation that may pose less risk of injury to the SAN.
Our data are in agreement with previously published reports in that the majority of cervical metastases in WDTC occur in levels II, III, and IV. In addition, we have demonstrated that multilevel lymph node metastasis is common (fi gure 2) and was seen in 72% of our ND specimens. Th is is also in agreement with previous reports in the literature. 1, 5, 10, 11 In addition to the high frequency of nodal metastases, we have demonstrated a high incidence of nodal metastases to level II-B (62%) and level V-B (31%). Simply removing a single node or even a nodal level may leave residual disease that might lead to the need for revision surgery and increased morbidity. Th e standard recommendations for the management of lateral cervical metastases are outlined in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and include removal of lymph node levels from levels II through V. 14 It is obvious that PTC can undergo extensive multilevel occult lymph node metastases beyond the clinically apparent node. Th erefore, we would recommend a formal comprehensive lymph node dissection to include levels II through V (including the level II-B lymph nodes).
